---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-154336"
form_type: "8-K"
ticker: "TCRX"
cik: "0001783328"
company_name: "TScan Therapeutics, Inc."
filed_at: "2025-07-02T23:59:59+00:00"
generated_at: "2026-05-18T09:40:23.260973+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# TScan Therapeutics holds annual meeting; elects three Class I directors and ratifies auditor

## Summary
- Elected Stephen Biggar, Gavin MacBeath, and Garry Nicholson as Class I directors for three-year terms through 2028.
- Garry Nicholson received 25.65M votes for and 5.86M withheld; Biggar and MacBeath each received >31M votes for.
- Ratified Deloitte & Touche as independent auditor for FY2025 with 45.72M votes for, 64K against, 36K abstain.
- Broker non-votes totaled 14.31M on director elections, indicating some institutional abstentions.

## SEC filing metadata
- accession: 0001193125-25-154336
- form_type: 8-K
- ticker: TCRX
- cik: 0001783328
- company_name: TScan Therapeutics, Inc.
- filed_at: 2025-07-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1783328/000119312525154336/0001193125-25-154336-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1783328/000119312525154336/d79904d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-154336
- JSON: https://secwatch.observer/filing/0001193125-25-154336.json
- Plain text: https://secwatch.observer/filing/0001193125-25-154336.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.